3Oreopoulos DG, Crassweller P, Katirtzoglou A,et al. Amino acids as an osmotic agent( instead of glucose)in continuous ambulatory peritoneal di- alysis. In: Legrain M, ed. Proceedings of an internalional symposium [M]. Amsterdam : Excerpta Medica, 1979 : 355-40.
4Kopple JD, Bernard D, Messana J,et al. Treatment of malnourished CAPD patients with an amino acid based dialysate [J]. Kidney Int, 1995 ;47 (4) :1148-57.
3Jessen KR, Thorpe R, Mirsky R. Molecular identity, distribu- tion and heterogeneity of glial fibrillary acidic protein: An im- munoblotting and immunohistochemical study of Schwann cells,satellite cells, enteric glia and astrocytes. J Neurocytol, 1984,13: 187-200.
4Ehlers S, Kyllerman M, Rosengren L. Analysis of glial fibrillar- y acidic protein in the cerebrospinal fluid of children investiga- ted for encephalopathy. Neuropediatrics, 1994,25 : 129-133.
5Herrmann M, Vos P, Wunderlich MT, et al. Release of glial tis- sue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary a- cidic protein. Stroke, 2000,31 : 2670-2677.
6Fraser DD, Close TE, Rose KL, et al. Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cere- brospinal fluid and serum, l~ediatr Crit Care Med, 2011,12: 319-324.
7Nyl6n K,Ost M,Csajbok LZ, et al. Increased serum-GFAP in patients with severe traumatic brain injury is related to out- come. J Neurol Sci,2006,240:85-91.
8De Deyn PP, Vanholder R, Eloot S, et al. Guanidino compounds as uremic (neuto) toxins. Semin Dial, 2009,22 : 340-345.
9Hosoya K, Tachikawa M. Roles of organic anion/cation trans- porters at the blood-brain and blood-cerebrospinal fluid barri- ers involving uremic toxins. Clin Exp Nephrol, 2011,15: 478- 485.
10Heidland A, Sebekova K, Klassen A, et al. Mechanisms of a- cute uremic encephalopathy: Early activation of Fos and Fra-2 gene products in different nuclei/areas of the rat brain. J Ren Nutr, 2010,20:S44-50.
